ask="28.40"
ask_size="100"
average_daily_volume="837110"
bid="28.00"
bid_size="700"
book_value="5.75"
change="+1.90"
change_from_200_day_moving_average="9.61"
change_from_50_day_moving_average="9.22"
change_from_52_week_high="-0.95"
change_From_52_week_low="15.91"
change_in_percent="+7.24%"
close="28.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.25"
ebitda="-70.16M"
eps_estimate_current_year="-2.39"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.79"
ex_dividend_date="N/A"
float_shares="24854000"
high="28.45"
high_52_weeks="29.10"
last_trade_date="2/24/2017"
last_trade_price="28.15"
last_trade_size="17411"
last_trade_time="4:00pm"
low="25.74"
low_52_weeks="12.24"
market_capitalization="1.05B"
moving_average_200_day="18.54"
moving_average_50_day="18.93"
name="Global Blood Therapeutics
Inc."
notes="N/A"
one_year_target_price="50.83"
open="26.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+51.85%"
percent_change_from_50_day_moving_average="+48.72%"
percent_change_from_52_week_high="-3.26%"
percent_change_from_52_week_low="+129.98%"
previous_close="26.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.56"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37316000"
short_ratio="9.70"
stock_exchange="NMS"
symbol="GBT"
volume="1503906"
weeks_range_52="12.24 - 29.10"
